| Drugs by Condition |  |
Weight Loss
Definition: Decrease in existing body weight.
See also: Obesity
Drugs (by generic name) associated with Weight Loss
The following drugs and medications are in some way related to, or used in the treatment of Weight Loss.
This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug Name  ( View by: Brand | Generic )
|
Reviews | Ratings |
|---|---|---|
phentermine systemic (Pro, More...) class: anorexiants, CNS stimulants | 75 Review(s) |
9.2
Rate It!
|
| megestrol systemic (Pro, More...)class: hormones/antineoplastics, progestins | 0 Review(s) | Not rated - Be the first |
| oxandrolone systemic (Pro, More...)class: androgens and anabolic steroids | 0 Review(s) | Not rated - Be the first |
| phenylpropanolamine systemic (More...)class: anorexiants, decongestants | 0 Review(s) | Not rated - Be the first |
Weight Loss Related Drugs in the Pipeline
Zimulti (rimonabant)
- November 14, 2007
Rimonabant - Regulatory Update in Europe - July 19, 2007
Committee for Medicinal Products for Human Use Post-authorisation Summary of Positive Opinion for Acomplia/Zimulti - June 29, 2007
Rimonabant Regulatory Update in the United States - June 14, 2007
Weight Loss Drug Rimonabant Can Cause Serious Physical and Psychological Harm and Birth Defects, Public Citizen Tells FDA - June 13, 2007
FDA Advisory Committee Did Not Recommend Approval of Rimonabant (Zimulti) for Use in Obese and Overweight Patients With Associated Risks Factors - March 26, 2007
Rimonabant USA: Update - March 26, 2007
Sanofi-aventis Acknowledges FDA Announcement of an Advisory Committee Meeting for rimonabant - February 12, 2007
Rimonabant USA: Update - December 8, 2006
Rimonabant Update in the United States - February 17, 2006
Sanofi-aventis Received from the FDA an Approvable Letter for Rimonabant for Weight Management and a Non Approvable Letter for Smoking Cessation - June 23, 2005
Rimonabant Accepted for Filing By the FDA
